Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

TMRW brings in $25mm Series B round in hopes of launching ivfOS IVF platform early next year

Executive Summary

TMRW Life Sciences Inc. (robotic platform designed for software-guided embryology and cryo-specimen management for in vitro fertilization (IVF)) raised $25mm in a Series B round led by new backer 5AM Ventures. The 2018 start-up’s ivfOS process automation platform manages the identification, freezing, storage, and retrieval of reproductive cells and embryos using radiofrequency identification (RFID)-enabled software-as-a-service (SaaS) digital chain of custody technology designed to eliminate sample management errors often found in manual and analog IVF methods. TMRW recently presented its initial validation study results for ivfOS and plans a commercial rollout in Q1 2020. In June of this year, the company raised a $12mm Series A round.
Deal Industry
  • Medical Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies